Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
12 November 2015
Header
Header image
News

News

EFPIA Responds to the Opinion of the Expert Panel of the Commission on Access to Health Services in the EU
06 November 2015

EFPIA welcomes the debate on access to health services, valuing its important contribution in the face of challenges to European health systems sustainability. It is [...] Read more

From our blog

From our blog

HCP Disclosure is Desirable and Will Improve Service to Patients
11 November 2015 by Alastair Kent (Genetic Alliance UK)

Anything that increases the transparency of the relationships between all of the stakeholders, be it doctors, scientists or patient representatives should be applauded.

Read more

Events calendar

Events Calendar

Emerging Medicinal Products – from laboratory to patient use
On 14/12/2015 (De Vere Centre, 1 Westferry Circus, Canary Wharf, London)

The fourth annual regulatory policy summit has been organised by EBE and the European Medicines Agency (EMA).

 

 

 

Read more

Documents

From our blog

Eco-Pharmaco-Stewardship (EPS) - Pillar 2 - Manufacturing: effluent management (Abstract)
09 October 2015 (Publications)

Read more

What we are reading

What we are reading

Drug pollution: Europe responds
12 November 2015 (Nature)

As directors of the Association of the European Self-Medication Industry (AESGP), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the European Generic and Biosimilar Medicines Association (EGA), respectively, we are committed to providing safe, efficient and high-quality medicines without releasing harmful components into the environment.

Read more

What we are reading

Solving The Problem Of Too Much Cancer Data
12 November 2015 (Forbes)

Cancer is not one disease – that’s why the effort to find a cure has been so challenging. Each type of cancer is different, and tumors vary genetically not just from type to type but from patient to patient. To better understand the molecular abnormalities that drive cancers, scientists have turned to next-generation sequencing (NGS), new technology that sequences DNA much more quickly and cheaply than previously used sequencing techniques.

Read more

Sessions Views

EFPIA Health Collaboration Summit - 28-29 October 2015, Brussels

EFPIA Health Collaboration Summit - 28-29 October 2015, Brussels
12 November 2015

The event brought together senior figures from patient organisations, healthcare systems and industry to discuss outcomes driven, sustainable healthcare in Europe and the role of transparency in developing effective working relationships, capacity building and governance.

View album

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail